<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382222</url>
  </required_header>
  <id_info>
    <org_study_id>20/16/205 - 001126</org_study_id>
    <nct_id>NCT04382222</nct_id>
  </id_info>
  <brief_title>Prenatal Screening for Congenital Heart Diseases in the Antwerp Region</brief_title>
  <acronym>SEC</acronym>
  <official_title>Sensitivity and Accuracy of Prenatal Diagnosis of Severe Congenital Heart Diseases in the Antwerp Region</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiteit Antwerpen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      No systematic research has been done in the last 15 years on the accuracy of prenatal
      ultrasound of congenital heart diseases in Belgium. Nor are there any population-based
      studies available on this subject for Belgium. Based on the data of EUROCAT (European
      Surveillance of Congenital Anomalies) the investigators analyse prenatal diagnostic
      sensitivity of congenital heart diseases in the EUROCAT regions Antwerp (Flanders, Belgium)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Congenital heart defects are a leading cause of infant mortality with an incidence of
      0,4-1,3% at birth. Although prenatal detection rates vary widely, morphological (structural)
      cardiac malformations are among the most frequently missed abnormalities by prenatal
      ultrasonography.

      However, identifying fetal cardiac abnormalities early in pregnancy is essential. Early
      diagnosis allows extensive cardiac ultrasound, genetic testing and planning delivery in a
      paediatric-cardiac centre offering optimal neonatal care.

      It also may allow the future parents to consider and decide for a termination of pregnancy in
      case of a severe fetal heart malformation with poor prognosis.

      The investigator conducts a retrospective study on 2500 cases of congenital heart diseases
      over 20 years. Detailed data for this were made available by the EUROCAT Antwerp registry, a
      population-based database with controlled, reliable and robust data.

      The study wants to reveal the prevalence and prenatal diagnostic sensitivity of congenital
      heart defects in the EUROCAT regions Antwerp (Flanders) and especially the evolution of the
      prenatal diagnostic rate over time.

      In the second phase, a similar study in two adjacent regions, Hainaut (Wallonia, Belgium) and
      Groningen (The Netherlands) will follow.

      On condition of correct statistic processing, these data will be suitable to compare the
      prevalence and to benchmark diagnostic rates of congenital heart defects in these three
      regions.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity and accuracy of prenatal ultrasound for cardiac malformations</measure>
    <time_frame>retrospective 20 years</time_frame>
    <description>retrospective analysis of prenatally missed and diagnosed congenital heart disaeses iseaersa</description>
  </primary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Congenital Heart Disease in Pregnancy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prenatal ultrasound</intervention_name>
    <description>prenatal cardiac ultrasound</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Low risk pregnancies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria

          -  All fetal congenital heart diseases registered in the Antwerp-EUROCAT database,

          -  In the period 1/1/1997-31/12/2017 period

        Exclusion criteria

          -  All cases of congenital heart diseases where the mother was under &lt;18 years old.

          -  All cases of congenital heart diseases were the parents did not allow inclusion in the
             EUROCAT registered.

          -  All cases of congenital heart diseases where the mother delivered outside the EC
             countries.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Ramaekers, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Antwerpen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yves Jacquemyn</last_name>
    <role>Study Chair</role>
    <affiliation>University Antwerpen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Ramaekers, MD</last_name>
    <phone>+32477772234</phone>
    <email>paul.ramaekers1@telenet.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yves Jacquemyn, PhD</last_name>
    <phone>+3238215945</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Antwerp</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiteit Antwerpen</investigator_affiliation>
    <investigator_full_name>Prof Yves Jacquemyn</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

